Publication | Closed Access

An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease

Idiopathic ParkinsonLevodopa Dose-sparing CapacityMedicineMulticentre Clinical TrialNeuropharmacologyPharmacotherapyNeurologyPharmacologyMovement Disorders